Detalhe da pesquisa
1.
Medication "underuse" headache.
Cephalalgia
; 44(4): 3331024241245658, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38613233
2.
Efficacy and quality-of-life improvements with fremanezumab treatment in patients with difficult-to-treat migraine with associated neurological dysfunction.
Eur J Neurol
; 29(7): 2129-2137, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35302681
3.
Diagnostic accuracy of an artificial intelligence online engine in migraine: A multi-center study.
Headache
; 62(7): 870-882, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35657603
4.
The Headache Pipeline: Excitement and Uncertainty.
Headache
; 60(1): 190-199, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31889312
5.
Remote Electrical Neuromodulation (REN) for the Acute Treatment of Migraine.
Headache
; 60(1): 229-234, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31913517
6.
Acute Care Treatment of Migraine.
J Neuroophthalmol
; 40(4): 472-484, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32956223
7.
Efficacy and safety of erenumab in women with a history of menstrual migraine.
J Headache Pain
; 21(1): 95, 2020 Aug 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32746775
8.
The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post-Hoc Analyses on the First 3 Weeks of Treatment.
Headache
; 59(3): 383-393, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30450545
9.
Some aspects on the pathophysiology of migraine and a review of device therapies for migraine and cluster headache.
Neurol Sci
; 40(Suppl 1): 75-80, 2019 May.
Artigo
Inglês
| MEDLINE | ID: mdl-30906962
10.
Putting a Positive Spin on the Phubbing Phenomenon.
South Med J
; 117(6): 350-351, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38830592
11.
Migraine and episodic Vertigo: a cohort survey study of their relationship.
J Headache Pain
; 20(1): 33, 2019 Apr 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30961522
12.
Remote electrical neuromodulation (REN) in the acute treatment of migraine: a comparison with usual care and acute migraine medications.
J Headache Pain
; 20(1): 83, 2019 Jul 22.
Artigo
Inglês
| MEDLINE | ID: mdl-31331265
13.
DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
Headache
; 58(5): 676-687, 2018 May.
Artigo
Inglês
| MEDLINE | ID: mdl-29878341
14.
A new era in headache treatment.
Neurol Sci
; 39(Suppl 1): 47-58, 2018 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-29904827
15.
Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled study.
J Headache Pain
; 19(1): 69, 2018 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30112726
16.
Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: an 8-week open-label extension study.
J Headache Pain
; 19(1): 70, 2018 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30112725
17.
The use of oxygen in cluster headache treatment worldwide - a survey of the International Headache Society (IHS).
Cephalalgia
; 37(4): 396-398, 2017 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-27121359
18.
Scent of aura? Clinical features of olfactory hallucinations during a migraine attack (OHM).
Cephalalgia
; 37(2): 154-160, 2017 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-27036639
19.
New treatments for headache.
Neurol Sci
; 38(Suppl 1): 145-156, 2017 May.
Artigo
Inglês
| MEDLINE | ID: mdl-28527051
20.
A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine.
J Headache Pain
; 18(1): 31, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-28251391